# Cooper Companies to acquire PARAGARD IUD from Teva for $1.1 billion

The Cooper Companies has entered into a definitive agreement to acquire the global rights and business of Teva's PARAGARD Intrauterine Device for $1.1 billion in cash. The deal includes Teva's manufacturing facility in Buffalo, NY.

- Type: Acquisition
- Announced: 2017-09-11
- Where: Buffalo, New York, United States
- Value: $1.10B
- Status: announced
- Products: PARAGARD Intrauterine Device
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cooper Companies](https://endata.com/companies/26842.md) (acquirer)
- [Teva Pharmaceutical Industries](https://endata.com/companies/26843.md) (target)

## Sources

- [investor.coopercos.com](https://investor.coopercos.com/news-releases/news-release-details/cooper-companies-announces-definitive-agreement-acquire), 2017-09-11: "The Cooper Companies, Inc. today announced it has entered into a definitive asset purchase agreement with Teva Pharmaceutical Industries Ltd. to acquire the global rights and business of its PARAGARD Intrauterine Device in a $1.1 billion cash transaction"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.